Lung Non-Squamous Non-Small Cell Carcinoma, also known as non- squamous nsclc, is related to lung cancer susceptibility 3 and exanthem. An important gene associated with Lung Non-Squamous Non-Small Cell Carcinoma is ALK (ALK Receptor Tyrosine Kinase), and among its related pathways/superpathways are Signal Transduction and RAF/MAP kinase cascade. The drugs Osimertinib and Afatinib have been mentioned in the context of this disorder. Affiliated tissues include lung and brain, and related phenotypes are Decreased viability and Increased shRNA abundance (Z-score > 2)